In this study, we found high expression of the HMGB1–TLR4 axis and its downstream signaling factors in patients with PD, which was positively associated with PD staging and duration and correlated with PD‐drug therapeutic outcomes. The gene discussed is TLR4; the disease is Parkinson disease.